Drug Type Fluorescent Peptide, Diagnostic radiopharmaceuticals |
Synonyms iSAP 0909, iSAP-0909 |
Target |
Action agonists |
Mechanism XIAP agonists(Inhibitor of apoptosis protein 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Muscle Invasive Bladder Neoplasms | IND Approval | United States | 04 Nov 2024 |





